Attached files
file | filename |
---|---|
EX-99.3 - EXHIBIT 99.3 - VIVEVE MEDICAL, INC. | ex_181765.htm |
EX-99.2 - EXHIBIT 99.2 - VIVEVE MEDICAL, INC. | ex_181764.htm |
EX-10.1 - EXHIBIT 10.1 - VIVEVE MEDICAL, INC. | ex_181763.htm |
EX-4.1 - EXHIBIT 4.1 - VIVEVE MEDICAL, INC. | ex_181762.htm |
8-K - FORM 8-K - VIVEVE MEDICAL, INC. | vive20200415c_8k.htm |
Exhibit 99.1
Viveve Medical, Inc.
342 Inverness Drive South,
Building B, Suite 250
Englewood, Colorado 80112
April 15, 2020
VStock Transfer, LLC
18 Lafayette Place
Woodmere, New York 11598
Attn: Young D. Kim, Esq.
Re: Viveve Medical, Inc. Series A Warrants (CUSIP: 92852W 121) and Series B warrants (CUSIP: 92852W 113)
Ladies and Gentlemen:
Please be advised that, effective April 15, 2020, pursuant to Section 3(g) of the Series A Common Stock Purchase Warrants of Viveve Medical, Inc. (the “Series A Warrants”) and Section 3(g) of the Series B Common Stock Purchase Warrant of Viveve Medical, Inc. (the “Series B Warrants”), the Exercise Price for the outstanding Series A Warrants and the Series B Warrants has been adjusted to $0.61 per share of common stock, par value $0.0001 per share (CUSIP 92852W204) (“Common Stock”).
|
Sincerely, |
||
|
|
||
|
VIVEVE MEDICAL, INC. |
||
|
|
||
|
|
|
|
|
By: |
/s/ Scott Durbin |
|
|
|
Scott Durbin |
|
|
|
Chief Executive Officer |